312 related articles for article (PubMed ID: 30049844)
1. Bleomycin-enhanced alternative splicing of fibroblast growth factor receptor 2 induces epithelial to mesenchymal transition in lung fibrosis.
Chen KJ; Li Q; Weng CM; Duan ZX; Zhang DD; Chen ZQ; Chen J; Wang JM
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30049844
[TBL] [Abstract][Full Text] [Related]
2. Bleomycin induces epithelial-to-mesenchymal transition via bFGF/PI3K/ESRP1 signaling in pulmonary fibrosis.
Weng CM; Li Q; Chen KJ; Xu CX; Deng MS; Li T; Zhang DD; Duan ZX; Chen ZQ; Li GH; Chen J; Wang JM
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31868203
[TBL] [Abstract][Full Text] [Related]
3. Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial-mesenchymal transition and fibroblast activation.
Chen YL; Zhang X; Bai J; Gai L; Ye XL; Zhang L; Xu Q; Zhang YX; Xu L; Li HP; Ding X
Cell Death Dis; 2013 Jun; 4(6):e665. PubMed ID: 23764846
[TBL] [Abstract][Full Text] [Related]
4. Atractylodin Suppresses TGF-β-Mediated Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells and Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice.
Chang KW; Zhang X; Lin SC; Lin YC; Li CH; Akhrymuk I; Lin SH; Lin CC
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681813
[TBL] [Abstract][Full Text] [Related]
5. Sunitinib, a Small-Molecule Kinase Inhibitor, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice.
Huang X; Wang W; Yuan H; Sun J; Li L; Wu X; Luo J; Gu Y
Tohoku J Exp Med; 2016 Aug; 239(4):251-61. PubMed ID: 27439438
[TBL] [Abstract][Full Text] [Related]
6. Myricetin ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-β signaling via targeting HSP90β.
Li X; Yu H; Liang L; Bi Z; Wang Y; Gao S; Wang M; Li H; Miao Y; Deng R; Ma L; Luan J; Li S; Liu M; Lin J; Zhou H; Yang C
Biochem Pharmacol; 2020 Aug; 178():114097. PubMed ID: 32535102
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Transforming Growth Factor-β/Smad-mediated Epithelial-Mesenchymal Transition by Celastrol Provides Protection against Bleomycin-induced Pulmonary Fibrosis.
Divya T; Velavan B; Sudhandiran G
Basic Clin Pharmacol Toxicol; 2018 Aug; 123(2):122-129. PubMed ID: 29394529
[TBL] [Abstract][Full Text] [Related]
8. Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation.
Guan R; Wang X; Zhao X; Song N; Zhu J; Wang J; Wang J; Xia C; Chen Y; Zhu D; Shen L
Sci Rep; 2016 Oct; 6():35696. PubMed ID: 27774992
[TBL] [Abstract][Full Text] [Related]
9. Deficiency of HtrA3 Attenuates Bleomycin-Induced Pulmonary Fibrosis Via TGF-β1/Smad Signaling Pathway.
Li G; Shen C; Wei D; Yang X; Jiang C; Yang X; Mao W; Zou J; Tan J; Chen J
Lung; 2023 Apr; 201(2):235-242. PubMed ID: 36823409
[TBL] [Abstract][Full Text] [Related]
10. miR-26a suppresses EMT by disrupting the Lin28B/let-7d axis: potential cross-talks among miRNAs in IPF.
Liang H; Liu S; Chen Y; Bai X; Liu L; Dong Y; Hu M; Su X; Chen Y; Huangfu L; Li X; Gu Y; Shan H
J Mol Med (Berl); 2016 Jun; 94(6):655-65. PubMed ID: 26787543
[TBL] [Abstract][Full Text] [Related]
11. MiR-326-mediated overexpression of NFIB offsets TGF-β induced epithelial to mesenchymal transition and reverses lung fibrosis.
Pattnaik B; Negi V; Chaudhuri R; Desiraju K; Faizan MI; Akhtar A; Ansari MS; Shakir M; Gheware A; Prakash YS; Guleria R; Ghosh B; Agrawal A; Ahmad T
Cell Mol Life Sci; 2023 Nov; 80(12):357. PubMed ID: 37950757
[TBL] [Abstract][Full Text] [Related]
12. miR-18a-5p Inhibits Sub-pleural Pulmonary Fibrosis by Targeting TGF-β Receptor II.
Zhang Q; Ye H; Xiang F; Song LJ; Zhou LL; Cai PC; Zhang JC; Yu F; Shi HZ; Su Y; Xin JB; Ma WL
Mol Ther; 2017 Mar; 25(3):728-738. PubMed ID: 28131417
[TBL] [Abstract][Full Text] [Related]
13. Metastasis-associated protein 1 promotes epithelial-mesenchymal transition in idiopathic pulmonary fibrosis by up-regulating Snail expression.
Qian W; Cai X; Qian Q; Zhang W; Tian L
J Cell Mol Med; 2020 Jun; 24(11):5998-6007. PubMed ID: 32187849
[TBL] [Abstract][Full Text] [Related]
14. miR‑221 targets HMGA2 to inhibit bleomycin‑induced pulmonary fibrosis by regulating TGF‑β1/Smad3-induced EMT.
Wang YC; Liu JS; Tang HK; Nie J; Zhu JX; Wen LL; Guo QL
Int J Mol Med; 2016 Oct; 38(4):1208-16. PubMed ID: 27513632
[TBL] [Abstract][Full Text] [Related]
15. Tannic acid attenuates TGF-β1-induced epithelial-to-mesenchymal transition by effectively intervening TGF-β signaling in lung epithelial cells.
Pattarayan D; Sivanantham A; Krishnaswami V; Loganathan L; Palanichamy R; Natesan S; Muthusamy K; Rajasekaran S
J Cell Physiol; 2018 Mar; 233(3):2513-2525. PubMed ID: 28771711
[TBL] [Abstract][Full Text] [Related]
16. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
[TBL] [Abstract][Full Text] [Related]
17. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
[TBL] [Abstract][Full Text] [Related]
18. Osteopontin silencing attenuates bleomycin-induced murine pulmonary fibrosis by regulating epithelial-mesenchymal transition.
Hatipoglu OF; Uctepe E; Opoku G; Wake H; Ikemura K; Ohtsuki T; Inagaki J; Gunduz M; Gunduz E; Watanabe S; Nishinaka T; Takahashi H; Hirohata S
Biomed Pharmacother; 2021 Jul; 139():111633. PubMed ID: 34243624
[TBL] [Abstract][Full Text] [Related]
19. M2 macrophages induce EMT through the TGF-β/Smad2 signaling pathway.
Zhu L; Fu X; Chen X; Han X; Dong P
Cell Biol Int; 2017 Sep; 41(9):960-968. PubMed ID: 28493530
[TBL] [Abstract][Full Text] [Related]
20. Krüpple-like-factor 4 Attenuates Lung Fibrosis via Inhibiting Epithelial-mesenchymal Transition.
Lin L; Han Q; Xiong Y; Li T; Liu Z; Xu H; Wu Y; Wang N; Liu X
Sci Rep; 2017 Nov; 7(1):15847. PubMed ID: 29158503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
